[Effect of glycine linoleamide on haloperidol and reserpine catalepsy in the rat].
D000818:Animals; D002375:Catalepsy / Q000139:chemically induced / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006220:Haloperidol / Q000633:toxicity*; D008041:Linoleic Acids / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000633:toxicity*
D008041:Linoleic Acids; C050349:glycine linoleamide; D012110:Reserpine; D006220:Haloperidol; D005998:Glycine
Effet du linoléamide de la glycine sur la catalepsie à l'halopéridol et à la réserpine chez le rat.